Next-Generation Anastomosis System for Minimally Invasive Surgery

Publication ID: 24-11857193_0010_PTD
Published: November 07, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Anastomosis System for Minimally Invasive Surgery,” Published Technical Disclosure No. 24-11857193_0010_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857193_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,193.

Summary of the Inventive Concept

A next-generation anastomosis system integrating nanorobotics, micro-suturing, and bio-absorbable materials for minimally invasive, high-precision surgical procedures.

Background and Problem Solved

The original patent disclosed methods and apparatuses for partial eversion anastomosis juncture formation and suturing. However, these methods are limited by their invasive nature, reliance on manual suturing, and potential for complications. The new inventive concept addresses these limitations by introducing a minimally invasive, automated, and adaptive anastomosis system.

Detailed Description of the Inventive Concept

The next-generation anastomosis system comprises a nanorobotics-based eversion mechanism, a micro-suturing module, and a bio-absorbable, shape-memory alloy stent. The nanorobotics-based eversion mechanism inverts a portion of an edge around an opening of a receiving passage, while the micro-suturing module joins the receiving passage to a donor passage. The bio-absorbable stent maintains the patency of the receiving passage during the anastomosis procedure and is subsequently absorbed after the procedure is complete. The system is controlled by a computer-aided design (CAD) system that predicts optimal suturing patterns and passage geometries based on patient-specific data and provides real-time feedback to the surgeon.

Novelty and Inventive Step

The new inventive concept's integration of nanorobotics, micro-suturing, and bio-absorbable materials represents a paradigm shift in anastomosis procedures, offering a minimally invasive, high-precision, and adaptive solution that overcomes the limitations of the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different nanorobotics architectures, micro-suturing materials, or bio-absorbable alloys. Variations could also include the integration of additional features, such as real-time imaging or haptic feedback, to further enhance the system's performance and usability.

Potential Commercial Applications and Market

The next-generation anastomosis system has significant commercial potential in the medical device industry, particularly in the areas of cardiovascular, gastrointestinal, and neurosurgery. The system's minimally invasive nature, high precision, and adaptability make it an attractive solution for surgeons and hospitals seeking to improve patient outcomes and reduce healthcare costs.

CPC Classifications

SectionClassGroup
A A61 A61B17/1152
A A61 A61B17/0469
A A61 A61B17/11
A A61 A61B90/361
A A61 A61B90/37
A A61 A61B2017/00566
A A61 A61B2017/1107
A A61 A61B2017/1121
A A61 A61B2017/1125
A A61 A61B2017/1132

Field of Art

Surgical Intervention Technologies, specifically minimally invasive surgical techniques for passage reconnection and anastomosis, requiring advanced knowledge of medical device engineering, microsurgical techniques, and biomedical materials science

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or surgical technology specialist with advanced degrees, expertise in medical device design, understanding of microsurgical techniques, familiarity with robotic surgical systems, and knowledge of biomaterials and surgical intervention strategies

Obviousness Rationale

A PHOSITA would recognize that the PTD's nanorobotics-based eversion and micro-suturing approach represents a predictable technological progression from the source patent's fundamental anastomosis method, utilizing known engineering principles of miniaturization, automation, and patient-specific customization to enhance surgical precision and reduce invasiveness.

Obvious Combinations & Variations

Source Patent Element
Method of everting distal portions of donor and receiving passages
PTD Variation
Nanorobotics-based eversion mechanism with computer-aided design integration
Obviousness Reasoning
Applying robotic precision to an existing eversion technique represents a predictable technological enhancement using known miniaturization and automation strategies
Source Patent Element
Suturing method involving guide sections and helical channels
PTD Variation
Micro-suturing module with machine learning-based optimal pattern prediction
Obviousness Reasoning
Incorporating computational intelligence into existing suturing techniques is a logical extension of known surgical technology optimization approaches
Source Patent Element
Surgical passage connection method
PTD Variation
Bio-absorbable shape-memory alloy stent for temporary passage maintenance
Obviousness Reasoning
Using advanced biomaterials to improve existing surgical techniques represents a standard approach of incremental medical technology development
Source Patent Element
Surgical passage connection technique
PTD Variation
Real-time optical coherence tomography monitoring with machine learning analytics
Obviousness Reasoning
Integrating advanced imaging and computational analysis into surgical procedures is a predictable technological progression in medical intervention technologies
Source Patent Element
Surgical method for passage connection
PTD Variation
Virtual reality training simulation with haptic feedback
Obviousness Reasoning
Developing advanced training technologies for surgical techniques using simulation is a standard approach to medical skills development
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857193 and the comprehensive technical disclosure herein, a person having ordinary skill in the art would find the claimed innovations of a nanorobotics-based anastomosis system with integrated micro-suturing, computational design, and advanced monitoring technologies to be obvious variations of the prior art, lacking inventive step under 35 U.S.C. ยง 103.

Original Patent Information

Patent NumberUS 11,857,193
TitlePartial eversion anastomosis juncture formation and suturing
Assignee(s)Gyrus ACMI, Inc.